Arrowhead Research reported $0 in Loan Capital for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.33M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 191.28M 191.28M
Arena Pharmaceuticals ARNA:US $ 41.21M 1.16M
Arrowhead Research ARWR:US $ 0 0
Bluebird Bio BLUE:US $ 0M 0M
Cerulean Pharma CERU:US $ 0 0
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
Heron Therapeutics HRTX:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 560.58M 7.37M
Ligand Pharmaceuticals LGND:US $ 442.29M 12.68M
Merk MRK:US $ 25360M 961M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 109.87M 1.26M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NOVN:VX SF 27978M 203M
Opko Health OPK:US $ 228.63M 2.89M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.7M 0.7M
Vertex Pharmaceuticals VRTX:US $ 539.04M 7.47M
Xencor XNCR:US $ 0M 0M
YTE INCY:US $ 32.57M 0.28M